Octapharma Reports octagam(R) 5% and octagam(R) 10% Global S(2)

This news release contains forward-looking statements， which include known and unknown risks， uncertainties and other factors not under the company's control. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. These factors include results of current or pending research and development activities and actions by the FDA or other regulatory authorities.

SOURCE Octapharma Group